1. ECHA
  2. RECHERCHE DE SUBSTANCES CHIMIQUES
  3. PACT - Outil de coordination des activités publiques

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

Back to the List

resorcinol; 1,3-benzenediol

EC / List no: 203-585-2 CAS no: 108-46-3
Collapse AllExpand All
Data generation and assessment
DEv - Dossier evaluation
DEv 1
Scope
Targeted
Status
Concluded
Decision date
Decision
Latest update
26-nov.-2022
Additional information
ECHA has performed an assessment and did not issue a decision.
More information View
SEv - Substance evaluation (Community Rolling Action Plan (CoRAP))
SEv 1
Evaluating Member State
France
Co-Evaluating Member State
Initial grounds for concern
Potential endocrine disruptor
High (aggregated) tonnage
Year
2019
Status
Information requested
Conclusion document
Latest update
19-janv.-2023
More information View
SEv 2
Evaluating Member State
Finland
Co-Evaluating Member State
Initial grounds for concern
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Wide dispersive use
Year
2016
Status
Concluded
Conclusion document
SUBSTANCE EVALUATION CONCLUSION and EVALUATION REPORT
Latest update
25-mars-2020
More information View
ED - Endocrine disruptor assessment
ED 1
Authority
France
Status
Under development
Outcome
Under development (other)
Hazard assessment outcome document
Remarks
SVHC identification. Scope: Endocrine disrupting properties (Article 57(f) - human health)
Under decision making by the European Commission
Concern
Endocrine disruption
Date of intention
04-nov.-2019
Date of hazard assessment
Latest update
03-févr.-2021
More information View
ED 2
Authority
France
Status
Under development under SEV
Outcome
Under development (SEV)
Hazard assessment outcome document
Remarks
Initial grounds for concern: potential endocrine disruptor for the environment
Concern
Endocrine disruption
Date of intention
11-sept.-2018
Date of hazard assessment
Latest update
03-févr.-2021
More information View
ED 3
Authority
Finland
Status
Concluded
Outcome
inconclusive
Hazard assessment outcome document
Remarks
Initial grounds of concern: ED ENV. No further testing was requested under the evaluation procedure carried by the Finnish MSCA (more information is available in the Substance Evaluation Conclusion Document). Note that the French MSCA is conducting a new substance evaluation on resorcinol to clarify the potential ED effects for the environment.
Concern
Endocrine disruption
Date of intention
13-sept.-2016
Date of hazard assessment
Latest update
03-févr.-2021
More information View
Regulatory risk management
CLH - Harmonised classification and labelling
CLH 1
Status
Intention
Date of intention
31-août-2023
Withdrawal date
Submitter
France
Proposed harmonised classification by the dossier submitter
Acute Tox. 4*, H302
Skin Irrit. 2, H315
Eye Irrit. 2, H319
ED HH 1, EUH380
Aquatic Acute 1, H400
Remarks
Date of opinion
RAC Opinion
Latest update
02-avr.-2024
More information View
CLH 2
Status
Opinion Adopted
Date of intention
31-déc.-2019
Withdrawal date
Submitter
Finland
Proposed harmonised classification by the dossier submitter
Acute Tox. 4, H302
Skin Irrit. 2, H315
Eye Irrit. 2, H319
Skin Sens. 1A, H317
STOT SE 1, H370
Aquatic Acute 1, H400
Aquatic Acute 1, M-factor=1
Skin sensitisation
Remarks
Date of opinion
16-sept.-2021
RAC Opinion
clh_opinion_resorcinol ISO)_en.pdf
Latest update
26-juil.-2022
More information View
SVHC - Substances of very high concern
SVHC 1
Status
Under decision making by the European Commission
Date of intention
12-août-2019
Withdrawal date
Submitter
France
Remarks
Scope
Endocrine disrupting properties (Article 57(f) - human health)
Date of inclusion in Candidate List
Latest update
01-juil.-2020
More information View
Assessment of regulatory needs
ARN 1
Authority
Finland
Concern
Endocrine disruption
Status
Concluded
Follow-up
CLH
Foreseen regulatory need
Summary document
ec_203-585-2_resorcinol_rmoa_concl_en.pdf
Group name
Remarks
Date of intention
29-août-2017
Date of assessment
17-mai-2018
Latest update
24-nov.-2021
More information View

List entry date: 14-janv.-2016

Export search results to: